Table 2.

Assessment of comorbidities in the psoriasis group and control group (chi-square test)

	Psoriasis group	Control group		p-value
Presence of comorbidity	54 (72%)	34 (45.3%)	88 (65.10%)	0.023
SAH	18 (24%)	14 (18.6%)		0.43
DM	14 (18.6%)	8 (10.7%)		0.17
Dyslipidemia	16 (21.3%)	7 (9.3%)		0.042
Absence of comorbidity	19 (25.3%)	28 (37.3%)	47 (34.81%)
Missing data	2 (2.6%)	13 (17.3%)

SAH - systemic arterial hypertension; DM - diabetes mellitus